Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

被引:52
|
作者
Mateo, Lourdes [1 ]
Holgado, Susana [1 ]
Marinoso, Maria Luisa [2 ]
Perez-Andres, Ricard [3 ]
Bonjoch, Anna [4 ,5 ]
Romeu, Joan [5 ]
Olive, Alejandro [1 ]
机构
[1] Univ Hosp Germans Trias & Pujol, Rheumatol Serv, Carretera Canyet S-N, Barcelona 08916, Spain
[2] Hosp del Mar, Pathol Serv, Barcelona, Spain
[3] Univ Hosp Germans Trias & Pujol, Serv Radiol, Carretera Canyet S-N, Barcelona 08916, Spain
[4] Univ Hosp Germans Trias & Pujol, Lluita SIDA Fdn, Carretera Canyet S-N, Barcelona 08916, Spain
[5] Univ Hosp Germans Trias & Pujol, Dept Internal Med, Carretera Canyet S-N, Barcelona 08916, Spain
关键词
Fanconi syndrome; HIV; Hypophosphatemic osteomalacia; Osteomalacia; Proximal renal tubulopathy; Tenofovir; RENAL TUBULAR DYSFUNCTION; CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; FANCONI SYNDROME; FRACTURES; THERAPY; SAFETY; COMBINATION; PREVALENCE; FAILURE;
D O I
10.1007/s10067-014-2627-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tenofovir disoproxil fumarate (TDF) is an adenine analogue reverse transcription inhibitor widely used in first-line treatment of human immunodeficiency virus (HIV) infection and also in hepatitis B virus infection. Its use has been linked to sporadic Fanconi syndrome, renal failure and bone disease. We present the clinical characteristics of tenofovir-induced osteomalacia, discuss bone biopsy findings, describe predisposing factors and compare our results with other reported cases. We describe five cases of hypophosphatemic osteomalacia induced by TDF and recorded at the rheumatology service of a university hospital between 2010 and 2014. We also report the characteristics of bone biopsies of this pathology, which have not been previously described. We include a review of published cases of proximal renal tubulopathy (PRT) and osteomalacia induced by TDF (PubMed 1995-2014; keywords: osteomalacia, tenofovir, Fanconi syndrome, hypophosphatemic osteomalacia, proximal renal tubulopathy, bone biopsy). Five HIV patients who developed hypophosphatemic osteomalacia under TDF treatment (> 5 years) presented increasing bone pain and a progressive inability to walk without assistance as a result of multiple insufficiency fractures. Bone biopsy performed in three patients after tetracycline labelling showed increased osteoid thickness, confirming osteomalacia. A literature review retrieved 17 publications on this condition, including 53 cases: 26 patients developed isolated PRT, 25 presented PRT and with multiple insufficiency fractures and two presented isolated bone disease, including osteomalacia and osteoporosis. Rheumatologists should be alert to this complication in patients receiving tenofovir. The main complaint reported by these patients is diffuse pain, predominantly in the lower limbs, indicating multiple stress fractures. Serum phosphate and appropriate screening for abnormal proximal tubule function should be monitored. Bone scintigraphy should be carried out in cases of limb pain before the occurrence of more severe complications.
引用
收藏
页码:1271 / 1279
页数:9
相关论文
共 50 条
  • [41] TUMOR-INDUCED HYPOPHOSPHATEMIC OSTEOMALACIA
    AUVERTCOLIN, L
    ASSELIN, F
    HEITZMANN, A
    GOUPILLE, P
    RUCHOUX, MM
    BEUTTER, P
    VALAT, JP
    SEMAINE DES HOPITAUX, 1990, 66 (23): : 1419 - 1422
  • [42] Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients
    Rodriguez Quesada, Pedro
    Lopez Esteban, Laura
    Ramon Garcia, Jimena
    Vazquez Sanchez, Rocio
    Molina Garcia, Teresa
    Gaspar Alonso-Vega, Gabriel
    Sanchez-Rubio Ferrandez, Javier
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (05) : 865 - 872
  • [43] The Deleterious Influence of Tenofovir-Based Therapies on the Progression of Atherosclerosis in HIV-Infected Patients
    Aragones, Gerard
    Pardo-Reche, Pedro
    Fernandez-Sender, Laura
    Rull, Anna
    Beltran-Debon, Raul
    Rodriguez-Gallego, Esther
    Camps, Jordi
    Joven, Jorge
    Alonso-Villaverde, Carlos
    MEDIATORS OF INFLAMMATION, 2012, 2012
  • [44] Evaluation of cardiovascular biomarkers In HIV-infected patients switching to abacavir or tenofovir based therapy
    Rasmussen, Thomas A.
    Tolstrup, Martin
    Melchjorsen, Jesper
    Frederiksen, Christian A.
    Nielsen, Ulla S.
    Langdahl, Bente L.
    Ostergaard, Lars
    Laursen, Alex L.
    BMC INFECTIOUS DISEASES, 2011, 11
  • [45] Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients
    Pedro Rodríguez Quesada
    Laura López Esteban
    Jimena Ramón García
    Rocío Vázquez Sánchez
    Teresa Molina García
    Gabriel Gaspar Alonso-Vega
    Javier Sánchez-Rubio Ferrández
    International Journal of Clinical Pharmacy, 2015, 37 : 865 - 872
  • [46] The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected Persons
    Fletcher, Courtney V.
    Podany, Anthony T.
    Thorkelson, Ann
    Winchester, Lee C.
    Mykris, Timothy
    Anderson, Jodi
    Jorstad, Siri
    Baker, Jason V.
    Schacker, Timothy W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (05) : 971 - 975
  • [47] Tenofovir plus didanosine as NRTI backbone in HIV-infected subjects
    Bongiovanni, Marco
    Tordato, Federica
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (23) : 2789 - 2793
  • [48] Prevalence and significance of proximal renal tubular abnormalities in HIV-infected patients receiving tenofovir
    Casado, Jose L.
    Banon, Sara
    Santiuste, Carmen
    Serna, Jorge
    Guzman, Paula
    Tenorio, Maite
    Liano, Fernando
    del Rey, Jose M.
    AIDS, 2016, 30 (02) : 231 - 239
  • [49] IMPROVEMENT IN CHRONIC RENAL IMPAIRMENT FOLLOWING THE DISCONTINUATION OF TENOFOVIR IN TWO HIV-INFECTED PATIENTS
    Gracey, David
    Post, Jeffrey
    MacLeod, Colin
    McKenzie, Paul
    NEPHROLOGY, 2011, 16 (04) : 453 - 455
  • [50] Predictors of Kidney Tubular Dysfunction in HIV-Infected Patients Treated with Tenofovir: A Pharmacogenetic Study
    Rodriguez-Novoa, Sonia
    Labarga, Pablo
    Soriano, Vincent
    Egan, Deirdre
    Albalater, Marta
    Morello, Judit
    Cuenca, Lorena
    Gonzalez-Pardo, Gema
    Khoo, Saye
    Back, David
    Owen, Andrew
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (11) : E108 - E116